SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is trending as community members rally around its ecosystem and staking yields, while investors closely monitor technical support levels amid broader crypto market volatility. Discussions are heavily focused on the resilience of the network, the potential for long-term growth, and the accumulation of various Solana-based tokens despite fluctuating sentiment.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is seeing a surge in investor interest driven by momentum in its weight-loss peptide offerings and potential regulatory milestones. While bullish sentiment is bolstered by recent analyst upgrades and strong price action, the community remains divided between those anticipating a short squeeze and skeptics wary of the stock's historical volatility.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

Serve Robotics is capturing investor attention as the company scales its autonomous sidewalk delivery fleet and expands into new verticals like healthcare logistics, leading many in the community to weigh its long-term potential against heavy short interest and ongoing dilution concerns. The stock remains a major focal point for traders tracking the broader robotics theme, with participants actively debating the impact of upcoming earnings and the potential for a technical breakout driven by its strategic partnerships.

JetBlue Airways Corp. engages in the provision of air transportation services. Its brands include jetBlue, jetBlue Vacations, Paisly, and TrueBlue. It operates through the following geographic segments: Domestic and Canada, Caribbean and Latin America, and Atlantic. The company was founded by David Gary Neeleman in August 1998 and is headquartered in Long Island City, NY.

Jetblue Airways Corp

JetBlue is experiencing significant market volatility and trading volume as investors react to reports that the company has retained financial advisors to explore potential strategic alternatives, including a possible sale or merger. While the stock initially surged on rumors of acquisition interest from major carriers, community discussion remains polarized between those speculating on a lucrative buyout premium and skeptics who highlight the airline's debt load, persistent operating pressures, and regulatory hurdles in the current antitrust environment.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

The Roundhill Magnificent Seven ETF is currently in focus as investors analyze the group's critical role in market breadth following a period of technical consolidation and mixed earnings reactions. Community sentiment is largely divided between concerns over AI-related capital expenditure sustainability and bullish expectations that mega-cap leadership will drive a year-end rally as the market seeks stability amid shifting macroeconomic conditions.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodrome Finance is currently trending as investors anticipate a major mainnet expansion to Ethereum in July alongside the launch of predictive allocation mechanisms. The community is actively discussing its status as a core liquidity hub for the Base ecosystem, with many viewing current price action as a key accumulation opportunity ahead of these upcoming catalysts.

Symbotic, Inc. is an automation technology company, which engages in a robotics and automation-based product movement technology platform. It focuses on developing, commercializing, and deploying innovative, end-to-end technology solutions for supply chain operations. It operates through the United States and Canada geographical segments. The company was founded by Richard B. Cohen on December 11, 2020 and is headquartered in Wilmington, MA.

Symbotic Inc - Ordinary Shares - Class A

Symbotic Inc 

Symbotic is seeing heightened community discussion as investors debate whether to view recent volatility as a buying opportunity given its massive, long-term warehouse automation backlog or as a risk due to customer concentration and insider selling. Market participants are actively tracking the stock's pivot toward physical AI and robotics as a core thematic play, often looking for entry points near technical support levels.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is facing intense scrutiny as investors debate its long-term viability amid shifting consumer habits and broader concerns over fast-food affordability. The community remains deeply divided, with some betting on a rebound as a defensive value play, while others are actively shorting the stock, citing technical weakness and the potential impact of weight-loss medication trends on the industry.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The biotech sector is experiencing significant volatility and rotation, as investors weigh potential M&A catalysts and clinical readouts against broader macro-economic concerns, including rising bond yields and sector-wide regulatory scrutiny. The community remains focused on high-conviction clinical-stage assets, balancing enthusiasm for potential breakthroughs in oncology and metabolic disease against a cautious outlook regarding the broader economic climate impacting small-cap biotech valuations.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is seeing intense community debate as some users advocate for migration to newer tokens on the Base network, while long-term holders continue to defend the project despite persistent skepticism regarding its supply and performance. The conversation remains polarized between those anticipating a recovery and critics labeling the asset a legacy project with declining momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

If You Invested $100 In Thermo Fisher Scientific Stock 15 Years Ago, You Would Have This Much Today

Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 15 years by 1.73% on an annualized basis producing an average annual return of 14.21%. Currently, Thermo Fisher Scientific has a marketread more...

Here's How Innovation Fuels Globus Medical's Growth Momentum

GMED is accelerating product launches, FDA clearances and R&D investment, reinforcing its strategy to expand spine and orthopedic workflows.

ICON Stock Valuation vs Peers: Is ICLR Cheap Enough?

ICLR looks cheap at 14.7x forward EPS versus peers, but 2026 guidance calls for lower revenue/EPS and a weak margin starting point.

ICLR Earnings Reset: What the Accounting Probe Changed

ICON plc details an accounting restatement, flags control weaknesses, and frames 2026 as a reset year amid mix-driven earnings swings.

TransMedics (TMDX) Down 4.4% Since Last Earnings Report: Can It Rebound?

TransMedics (TMDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

QuidelOrtho's Respiratory Exposure Remains a Key Near-Term Risk

QDEL's Q1 results show how a milder respiratory season can pressure revenue, margins and cash flow despite stable testing market share.

The Zacks Analyst Blog Highlights Microsoft, Dell, Thermo Fisher,Village Super Market and  Comstock 

MSFT is benefiting from AI momentum, Copilot adoption and accelerating Azure growth, even as capacity constraints persist.

Top Analyst Reports for Microsoft, Dell & Thermo Fisher

Microsoft, Dell and Thermo Fisher lead today's analyst picks as AI demand, cloud growth and biotech expansion shape outlooks and key risks.

Thermo Fisher (TMO) Surges 6.8%: Is This an Indication of Further Gains?

Thermo Fisher (TMO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Is QGEN Stock a Hold After the 2026 Outlook Cut and Q1 Miss?

QIAGEN cuts its 2026 growth outlook after a Q1 miss, but margins, cash flow and a debt-free balance sheet could steady the narrative.

Thermo Fisher Scientific Inc. offers products and services to customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, and diagnosis of disease. The Analytical Instruments segment offers instruments and supporting consumables, software and services. The Specialty Diagnostics segment provides diagnostic test kits, reagents, culture media, instruments and associated products to healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The Laboratory Products and Biopharma Services segment offers outsourced services used by the pharmaceutical and biotech industries for drug development, clinical research, clinical trials services and commercial drug manufacturing. The company was founded in July 1956 and is headquartered in Waltham, MA.

Thermo Fisher Scientific Inc.

SLS Stock Jumps Premarket: US Investor Dagco Boosts Stake By 78% Ahead Of Fresh Cancer Drug Data Reveal 

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

TMOThermo Fisher Scientific Inc.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TMO News